GlassScriptPhysician profile
Christopher Andrew Bloss
NPI 1518909209
$879.81
in general payments reported to CMS, 2019-2025
15 companies · $362 in 2025
The $362 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $81.15 · 2020: $34.99 · 2021: $357 · 2023: $18.82 · 2024: $25.87 · 2025: $362.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $407.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $407.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $356.52 | 2021 | |
| Sumitomo Pharma America, INC. | $87.53 | 2025 | Myfembree, Gemtesa |
| Exeltis, USA INC. | $84.82 | 2025 | Slynd |
| Millicent US INC | $52.62 | 2025 | Femlyv |
| Astellas Pharma US INC | $49.29 | 2019-2025 | Veozah |
| Vertex Pharmaceuticals Incorporated | $46.60 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $41.12 | 2025 | |
| Biogen, INC. | $25.87 | 2024 | |
| Boston Scientific Corporation | $23.97 | 2025 | Axonics |
| Coopersurgical, INC. | $23.55 | 2019-2020 | |
| Pfizer INC. | $22.85 | 2019-2020 | |
| Radius Health, INC. | $20.68 | 2019 | |
| Olympus America INC. | $18.82 | 2023 | |
| Hologic Sales and Service, LLC | $12.86 | 2020 | |
| Amag Pharmaceuticals, INC. | $12.71 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Bloss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.